Loxo Oncology Email Format
Biotechnology ResearchNew York, United States11-50 Employees
Loxo Oncology is a biotechnology company focused on developing cancer therapies for well-defined patient groups whose tumors share common genetic drivers. Based in New York, New York, it operates within the biotechnology research industry and concentrates on targeted oncology drugs for genetically defined cancer subtypes. The company’s work targets patients whose cancers arise from shared genetic alterations, aiming to address unmet clinical needs in these subgroups. A notable development in its history includes a 2021 collaboration with Foghorn Therapeutics to leverage its Gene Traffic Control platform to advance its oncology pipeline. The organization maintains a relatively small team and operates within the broader oncology and biotech ecosystem.